Carelabs Co.,Ltd Share Price

Equities

A263700

KR7263700007

Software

End-of-day quote Korea S.E. 03:30:00 30/04/2024 am IST 5-day change 1st Jan Change
4,005 KRW +1.26% Intraday chart for Carelabs Co.,Ltd +2.17% -7.61%

Financials

Sales 2022 87.61B 63.25M 5.28B Sales 2023 81.83B 59.08M 4.93B Capitalization 84.1B 60.72M 5.07B
Net income 2022 -26.12B -18.86M -1.57B Net income 2023 -24.47B -17.67M -1.47B EV / Sales 2022 1.68 x
Net Debt 2022 26.75B 19.31M 1.61B Net Debt 2023 29.84B 21.55M 1.8B EV / Sales 2023 1.39 x
P/E ratio 2022
-4.54 x
P/E ratio 2023
-3.36 x
Employees 83
Yield 2022 *
-
Yield 2023
-
Free-Float 67.53%
More Fundamentals * Assessed data
Dynamic Chart
Humanscape, Inc. announced that it has received KRW 20 billion in funding from a group of investors CI
Carelabs Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Wonik Holdings Co., Ltd completed the acquisition of 23.27% stake in Carelabs Co.,Ltd from Citylabs Co.,Ltd.. CI
Tranche Update on Carelabs Co.,Ltd's Equity Buyback Plan announced on October 14, 2021. CI
Tranche Update on Carelabs Co.,Ltd's Equity Buyback Plan announced on October 14, 2021. CI
Tranche Update on Carelabs Co.,Ltd's Equity Buyback Plan announced on October 14, 2021. CI
Carelabs Co.,Ltd's Equity Buyback announced on October 14, 2021, has expired with 14,221 shares, representing 0.08% for KRW 113.63 million. CI
Carelabs Co.,Ltd authorizes a Buyback Plan. CI
Carelabs Co.,Ltd announces an Equity Buyback for KRW 2,000 million worth of its shares. CI
Carelabs Co.,Ltd announced that it has received KRW 11 billion in funding from PSI International, Inc., NH Investment & Securities Co., Ltd., Investment Arm, KB Securities Co., Ltd., Investment Arm CI
Carelabs Co.,Ltd announced that it has received KRW 20 billion in funding from Mirae Asset Daewoo Co., Ltd., Investment Arm, Korea Investment & Securities Co., Ltd., Investment Arm, KB Securities Co., Ltd., Investment Arm CI
Carelabs Co.,Ltd announced that it expects to receive KRW 20 billion in funding from Mirae Asset Daewoo Co., Ltd., Investment Arm, Korea Investment & Securities Co., Ltd., Investment Arm, KB Securities Co., Ltd., Investment Arm CI
Humanscape, Inc. announced that it has received KRW 13.1 billion in funding from Korea Investment Partners Co. Ltd., Green Cross Holdings Corporation, Nau IB Capital, Investment Arm, Carelabs Co.,Ltd, KB Securities Co., Ltd., Investment Arm CI
Carelabs Co.,Ltd announced that it expects to receive KRW 20 billion in funding from PSI International, Inc., NH Investment & Securities Co., Ltd., Investment Arm, KB Securities Co., Ltd., Investment Arm CI
Carelabs Co.,Ltd's Equity Buyback announced on March 16, 2020, has expired. CI
More news
1 day+1.26%
1 week+2.17%
Current month-12.17%
1 month-12.17%
3 months-1.72%
6 months+1.65%
Current year-7.61%
More quotes
1 week
3 830.00
Extreme 3830
4 050.00
1 month
3 830.00
Extreme 3830
4 750.00
Current year
3 830.00
Extreme 3830
7 800.00
1 year
3 755.00
Extreme 3755
7 800.00
3 years
3 755.00
Extreme 3755
11 200.00
5 years
3 755.00
Extreme 3755
14 500.00
10 years
3 755.00
Extreme 3755
32 700.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 40 27/18/27
Chief Executive Officer 40 -
Director of Finance/CFO 47 01/16/01
Members of the board TitleAgeSince
Director/Board Member 76 27/18/27
Director/Board Member 41 27/18/27
Director/Board Member 50 27/18/27
More insiders
Date Price Change Volume
30/24/30 4,005 +1.26% 59,981
29/24/29 3,955 +1.41% 36,835
26/24/26 3,900 +1.17% 39,290
25/24/25 3,855 -2.90% 85,980
24/24/24 3,970 +2.98% 95,705

End-of-day quote Korea S.E., April 30, 2024

More quotes
Carelabs Co.,Ltd is a Korea-based company mainly engaged in the development and sale of software. Along with subsidiaries, the Company operates its business through three segments. The Healthcare Digital Marketing segment is involved in marketing planning, production and agency business. The Healthcare Media Platform segment is involved in the provision of hospital pharmacy search services and community apps related to beauty care. The products are sold under the name of GOODOC and BABITALK. The Healthcare Solution segment provides customer relationship management (CRM) software, prescription security systems, and pharmacy billing programs. The Company distributes its products within the domestic market and to overseas markets.
More about the company
  1. Stock Market
  2. Equities
  3. A263700 Stock